Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

IBM Watson Health

- PMLiVE

NHS taps technology firms for ‘connected’ patient projects

One of the pilots will see Google's Verily unit work with MSD on a telehealth initiative

- PMLiVE

Novartis’ Entresto launched in UK

Drug was first CHF therapy to show an improvement over ACE inhibitors

Novartis sets sights on connected inhaler

Plans 2019 launch for Qualcomm-partnered device

- PMLiVE

Adapting to the digital age

Sales dynamics are changing - but people, on both sides of the interaction, remain the ultimate driving force

Sanofi reception

Sanofi and Novartis snap up immuno-oncology candidates

Separate licensing deals see the firms look to catch up with the category's leaders

- PMLiVE

Mylan buys into six biosimilars, including Orencia candidate

Deal with Momenta bolsters biosimilars pipeline for new products

- PMLiVE

Baxalta and CTI complete filing for Jakafi rival in US

Myelofibrosis candidate pacritinib aiming for accelerated approval

- PMLiVE

Novo Nordisk will work with IBM on diabetes care

Development of digital platform to help diabetics and their doctors manage their illness

- PMLiVE

V is for Verily: life sciences’ new entry in Google’s Alphabet

Google [x]'s life sciences division renamed

Projects selected for MSD-backed digital accelerator

Disease-specific mobile apps among those winning support from Velocity Health

Novartis building

Novartis’ Entresto gets EU green light

Winsapproval for symptomatic chronic heart failure with reduced ejection fraction

Novartis building

Novartis’ Cosentyx cleared for wider use in Europe

Approved for psoriatic arthritis and ankylosing spondylitis

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links